Diltiazem Hydrochloride

CAS 33286-22-5 11 current records 16 historicalSmall Molecule

Who holds supplier records for Diltiazem Hydrochloride? 11 organisations hold a current record for Diltiazem Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 16 organisations have only historical (inactive) DMF filings. 8 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (5), Italy (3), Netherlands (1), Finland (1) and 1 other country (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Diltiazem Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/diltiazem-hydrochloride

Reading the evidence

  • 11 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 8 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (11)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Diltiazem Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Diltiazem Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (8)

Certificates of Suitability on the EDQM register for Diltiazem Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 13 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
F.I.S. FABBRICA ITALIANA SINTETICI S.P.A. Montecchio MaggioreIT
CEP 1998-036 - Rev 09
Diltiazem hydrochloride
Aug 2026Inspected Apr 2026
Italy
VASUDHA PHARMA CHEM LIMITED HyderabadIN
CEP 2024-490 - Rev 00
Diltiazem hydrochloride
Jul 2026—
TAPI NL B.V. AmsterdamNL
CEP 1997-077 - Rev 17
Diltiazem hydrochloride
Jun 2026—
PIRAMAL PHARMA LIMITED Digwal VillageIN
CEP 1997-121 - Rev 15
Diltiazem hydrochloride
Apr 2026Inspected Jun 2025
Netherlands
CHEMECA DRUGS PRIVATE LIMITED Tadi RevenueIN
CEP 2023-401 - Rev 00
Diltiazem hydrochloride
Mar 2026—
FLEMING LABORATORIES LIMITED Nawabpet VillageIN
R0-CEP 2020-181 - Rev 00
Diltiazem hydrochloride
Jan 2023—
DIVI'S LABORATORIES LIMITED HyderabadIN
R1-CEP 1999-156 - Rev 10
Diltiazem hydrochloride
Feb 2020—
Finorga S.A.S. MourenxFR
R1-CEP 1998-115 - Rev 05
Diltiazem hydrochloride
Jun 2018—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (16)

Organisations whose Type II DMFs for Diltiazem Hydrochloride are no longer active. These show a past filing, not current supply.

Show all 16 historical records
  • Czechia · Inactive DMF 15418 · filed May 2001
  • Taiwan · Inactive DMF 14659 · filed Jan 2000
  • India · Inactive DMF 13130 · filed Aug 1998
  • ORION CORP FERMION
    Inactive DMF 12071 · filed Aug 1996
  • India · Inactive DMF 11504 · filed May 1995
  • Japan · Inactive DMF 10381 · filed Jul 1993
  • SUMITRA PHARMACEUTICALS AND CHEMICALS LTD
    Inactive DMF 10466 · filed Jun 1993
  • TATEISHI SEIYAKU CO LTD
    Inactive DMF 8799 · filed Oct 1990
  • ICHIKAWA LAB CO LTD
    Inactive DMF 8706 · filed Aug 1990
  • HAMARI CO LTD
    Inactive DMF 8548 · filed May 1990
  • Argentina · Inactive DMF 7887 · filed Feb 1989
  • FABBRICA ITALIANA SINTETICI SPA
    Inactive DMF 7908 · filed Jan 1989
  • France · Inactive DMF 7756 · filed Oct 1988
  • France · Inactive DMF 7422 · filed Apr 1988
  • TORCAN CHEMICAL LTD
    Inactive DMF 7240 · filed Oct 1987
  • TANABE SEIYAKU CO LTD
    Inactive DMF 3059 · filed Nov 1977

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Diltiazem Hydrochloride is a calcium channel blocker used to treat hypertension, angina pectoris, and certain heart rhythm disorders. It works by relaxing blood vessels and reducing the workload on the heart.

Chemical identity

IUPAC name
[(2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] acetate;hydrochloride
Canonical SMILES
CC(=O)O[C@@H]1[C@@H](SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC.Cl
InChIKey
HDRXZJPWHTXQRI-BHDTVMLSSA-N
Synonyms
Cardizem API, adizem, altiazem, cardizem, cartia, crd-401, deltazen, dilacor, diladel, dilpral, dilrene, diltiazem hcl

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Calcium Channel Blocker
Mechanism of action
Calcium Channel Antagonists; Cytochrome P450 3A4 Inhibitors

Therapeutic areas

CardiovascularHypertensionAngina

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Diltiazem Hydrochloride?

11 organisations hold an active US FDA Type II Drug Master File or a CEP for Diltiazem Hydrochloride: CHEMECA DRUGS PRIVATE LTD (India), Divis Laboratories (India), FIS FABBRICA ITALIANA SINTETICI SPA (Italy), Piramal Pharma Limited (India), TAPI NL BV (Netherlands), VASUDHA PHARMA CHEM LTD (India), CAMBREX PROFARMACO MILANO SRL (Italy) and FERMION OY (Finland), and 3 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Diltiazem Hydrochloride Drug Master Files are active?

CHEMECA DRUGS PRIVATE LTD (DMF 34220), Divis Laboratories (DMF 15267), FIS FABBRICA ITALIANA SINTETICI SPA (DMF 7600), Piramal Pharma Limited (DMF 14713), TAPI NL BV (DMF 7239), VASUDHA PHARMA CHEM LTD (DMF 40722), CAMBREX PROFARMACO MILANO SRL (DMF 6761) and FERMION OY (DMF 5717) and 1 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Diltiazem Hydrochloride records mean?

16 organisations have only inactive Type II DMFs for Diltiazem Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Diltiazem Hydrochloride have a European Certificate of Suitability?

Yes. 8 organisations hold a valid CEP for Diltiazem Hydrochloride on the EDQM register, including F.I.S. FABBRICA ITALIANA SINTETICI S.P.A. Montecchio Maggiore (IT), VASUDHA PHARMA CHEM LIMITED Hyderabad (IN), TAPI NL B.V. Amsterdam (NL), PIRAMAL PHARMA LIMITED Digwal Village (IN), CHEMECA DRUGS PRIVATE LIMITED Tadi Revenue (IN) and FLEMING LABORATORIES LIMITED Nawabpet Village (IN) and 2 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Diltiazem Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Diltiazem Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.